# Carob Cholesterol Meta-analysis: What the Evidence Says
Canonical: https://www.migaku.app/guides/carob-cholesterol-meta-analysis-evidence-review
Category: evidence-review
Summary: Carob Cholesterol Meta-analysis has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are randomi
Last reviewed: 2026-08-01
Reviewed by: Migaku Evidence Review
# Carob Cholesterol Meta-analysis: What the Evidence Says

## Quick Answer

Carob Cholesterol Meta-analysis has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are randomized trial, so conclusions should be framed as evidence-aware guidance rather than medical advice.

## Key Takeaways

- This page is generated only from sources stored in the Migaku evidence knowledge base.
- Current evidence mix: 1 randomized trial, 1 preclinical study.
- Claims should be interpreted with the source type, study design, population, and publication date in mind.
- This article is educational and does not replace care from a qualified clinician.

## Evidence Map

| Source | Evidence type | Level | Date | Identifier |
| --- | --- | ---: | --- | --- |
| Effects of Specific Carob ( Ceratonia siliqua L.) Liquid Concentrate on Glucose Metabolism in Subjects with Prediabetes: A Randomized Double-Blind Controlled Clinical Trial | randomized trial | 2 | 2026-05-10 | 10.3390/nu18101521 |
| Carob ( Ceratonia siliqua L.) in Glucose Homeostasis and Energy Balance: The Role of D-Pinitol | preclinical study | 4 | 2026-04-25 | 10.3390/nu18091357 |

## What The Sources Report

- It is identified by increased glycated hemoglobin (HbA1c) or an abnormal oral glucose tolerance test. [Pérez-Piñero Silvia (2026); evidence level 2]
- Subjects with prediabetes have a high risk of progressing to diabetes, with an annualized conversion rate of 5-10%. [Pérez-Piñero Silvia (2026); evidence level 2]
- The global increase in obesity and associated metabolic disorders, including type 2 diabetes mellitus (T2DM), metabolic dysfunction-associated steatotic liver disease (MASLD), and cardiovascular disease (CVD), represents one of the major public health challenges of the 21st century. [Torres-Oteros Daniel (2026); evidence level 4]
- As a result, increasing attention has been directed toward naturally occurring dietary compounds capable of modulating appetite control, glucose homeostasis, lipid metabolism, and thermogenic/metabolic activity as complementary strategies for weight management and metabolic health. [Torres-Oteros Daniel (2026); evidence level 4]

## How To Read This Evidence

Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.

## Practical Interpretation

There is trial evidence in the current set, but population and intervention details still matter. For carob cholesterol meta-analysis, the next editorial step is to add more targeted sources and separate strong findings from early or indirect evidence.

## Limits Of This First Pass

This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.

## References

- Pérez-Piñero Silvia (2026). Effects of Specific Carob ( Ceratonia siliqua L.) Liquid Concentrate on Glucose Metabolism in Subjects with Prediabetes: A Randomized Double-Blind Controlled Clinical Trial. DOI: 10.3390/nu18101521. PMCID: PMC13210344. PMID: 42196981. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13210344/
- Torres-Oteros Daniel (2026). Carob ( Ceratonia siliqua L.) in Glucose Homeostasis and Energy Balance: The Role of D-Pinitol. DOI: 10.3390/nu18091357. PMCID: PMC13165371. PMID: 42123959. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13165371/

## Safety Note

Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.